Skip to main content
Camurus logo

Camurus — Investor Relations & Filings

Ticker · CAMX ISIN · SE0007692850 LEI · 5493003S6Z6VI7WYFQ06 ST Manufacturing
Open in API
Filings indexed 379 across all filing types
Latest filing 2026-05-12 Interim / Quarterly Rep…
Country SE Sweden
Listing ST CAMX

About Camurus

https://www.camurus.com/

Camurus is a science-led biopharmaceutical company that develops and commercializes innovative, long-acting medicines for severe and chronic diseases. The company specializes in advanced drug delivery systems designed to improve treatment outcomes, enhance patient quality of life, and provide value to society. Its therapeutic focus areas include opioid dependence, cancer and supportive care, endocrine conditions, rare diseases, and disorders of the central nervous system. Camurus maintains a diversified research and development pipeline to address significant unmet medical needs.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 95% confidence The document is titled “Delårsrapport Första kvartalet 2026” and provides detailed financial results, metrics and analysis for Q1 2026, including revenue, operating profit, net cash, segment analysis, tables of figures, and narrative commentary. It is a comprehensive interim/quarterly financial report rather than a brief earnings release or announcement of publication. Therefore, it matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-12 Swedish
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 92% confidence The document is clearly labelled “INTERIM REPORT FOR THE FIRST QUARTER 2026” and contains detailed quarter-to-quarter and year-to-date financial tables, P&L metrics, narrative business review, outlook commentary, and operational highlights. It provides substantive financial data and analysis for a period shorter than a full fiscal year, matching the definition of an Interim/Quarterly Report. Q1 2026
2026-05-12 English
Annual Report 2025
Annual Report Classification · 100% confidence The document is titled 'Årsredovisning 2025' which translates to 'Annual Report 2025' in English. It contains detailed sections typical of an annual report, including financial overview, management discussion, strategy, product pipeline, sustainability report, financial statements, auditor's report, governance report, and notes. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. It includes comprehensive financial data, management commentary, and audit information, consistent with an official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2025
2026-04-29 Swedish
Förändring av antalet aktier och röster i Camurus
Share Issue/Capital Change Classification · 87% confidence The document is a press release titled “Förändring av antalet aktier och röster i Camurus,” describing the exercise of employee stock options under ESOP 2022/2026 which has increased the number of shares and votes outstanding. This is an announcement of a change in the company’s share capital structure (new shares issued upon option exercise). Under the FinancialReports taxonomy, such announcements of share issuance and capital changes fall under Share Issue/Capital Change (Code: SHA).
2026-03-31 Swedish
Change in number of shares and votes in Camurus
Share Issue/Capital Change Classification · 95% confidence The document is a press release disclosing the exercise of employee stock options under ESOP 2022/2026, resulting in a change in the total number of shares and votes. This is an announcement of a share issuance/capital change rather than an annual or interim report, earning release, or regulatory guideline. It directly concerns the company’s share capital structure. Therefore it fits the Share Issue/Capital Change category (SHA).
2026-03-31 English
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 100% confidence The document is a 'Bokslutskommuniké' (Year-end report) for the company Camurus, covering the fourth quarter and the full year 2025. It contains detailed financial statements, management commentary on business performance, operational highlights, and future financial outlook. It is a comprehensive financial report for a period shorter than a full fiscal year (Q4) and the full year, fitting the definition of an Interim/Quarterly Report. Q4 2025
2026-02-12 Swedish

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.